Cryo-Cell International Financials - Benzinga

Cryo-Cell International Inc

CCELAMEX

Trade with Public

Trade with Public

$4.16

0.6317.85%

At close: Sep 22, 5:00 PM EST

$4.25

0.092.16%

After Hours: 5:15 PM EST

Overview News Earnings Forecast Price TargetsFinancialsSentiment Ownership Dividends Compare Stock Report

Cryo-Cell International Financials

Cryo-Cell International (CCEL) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Cryo-Cell International Q2 EPS $0.07 Up From $0.04 YoY, Sales $7.800M Down From $7.900M YoY

Cryo-Cell International (AMEX:CCEL) reported quarterly earnings of $0.07 per share. This is a 75 percent increase over earnings of $0.04 per share from the same period last year. The company reported $7.800 million in

Benzinga Newsdesk

PRO
Cryo-Cell International Q1 EPS $0.01 Beats $(0.10) Estimate, Sales $7.683M Beat $7.631M Estimate

Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.10) by 110 percent. This is a 66.67 percent decrease over earnings of $0.03 per share

Benzinga Newsdesk

PRO
Cryo-Cell International Q4 EPS $(0.13) Misses $(0.11) Estimate, Sales $7.843M Beat $7.731M Estimate

Cryo-Cell International (NASDAQ:CCEL) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 40.91 percent increase over losses of $(0.22) per

Benzinga Newsdesk

PRO
Cryo-Cell International Q3 EPS $0.09 Beats $(0.05) Estimate, Sales $7.830M Miss $7.981M Estimate

Benzinga Newsdesk

PRO
Cryo-Cell International Q2 EPS $0.04 Beats $(0.05) Estimate, Sales $7.929M Miss $8.041M Estimate

Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.05) by 180 percent. This is a 50 percent decrease over earnings of $0.08 per share

Benzinga Newsdesk

PRO
Cryo-Cell International Q1 2025 GAAP EPS $0.03 Beats $0.02 Estimate, Sales $7.97M Miss $8.04M Estimate

Benzinga Newsdesk